Vicki Moore, PhD

Contributing Writer https://www.hematologyadvisor.com

Vicki Moore, PhD, is a freelance medical writer for Hematology Advisor. Vicki received her PhD in biology from Arizona State University, where her research emphasized molecular biology, biochemistry, and metabolic engineering. She also has experience with predictive analytics and is intrigued by its applications to medicine. Vicki has been a medical writer, focusing on areas of hematology and oncology, among other specialties, since late 2017. You can find her on Linkedin at linkedin.com/in/vicki-moore-93950913

All articles by Vicki Moore, PhD

Telomerase plays a crucial role in tumor proliferation, and a better understanding of its structure

Myeloma

Loss of 2q37 Linked to Immunomodulatory Drug Resistance in Multiple Myeloma

Vicki Moore, PhD

November 22, 2022

Researchers sought to determine whether there was a connection between loss of the 2q37 chromosomal region and resistance to immunomodulatory drugs in MM.

Thrombotic Disorders

Study of Mirasol®-Based Pathogen Reduction in Platelets Fails to Meet Primary Endpoint

Vicki Moore, PhD

November 21, 2022

Researchers sought to determine the efficacy of a Mirasol®-based pathogen-reduction strategy for platelets.

Thrombotic Disorders

Risks of Intraventricular Hemorrhage and Death May Be Higher in Preterm Infants

Vicki Moore, PhD

November 18, 2022

Researchers sought to determine the risk of intraventricular hemorrhage and mortality in preterm infants with lower platelet counts.

General Hematology

Assisting Survivors Through Grief After the Loss of a Co-Parent to Cancer

Vicki Moore, PhD

November 14, 2022

A qualitative study sought to investigate the challenges faced by a surviving parent of dependent children after the cancer-related death of a co-parent.

Leukemia

FLT3-Targeted CAR-T Cells Show Antitumor Activity in KMT2A-Rearranged B-Cell Acute Lymphoblastic Leukemia

Vicki Moore, PhD

November 10, 2022

Researchers sought to determine whether FLT3-targeted CAR-T cells could have antitumor activity in patients with B-ALL with KMT2A rearrangement.

Doctor talking to older black female patient.

General Hematology

High-Dose Dexamethasone Not Recommended for Dyspnea With Cancer

Vicki Moore, PhD

November 10, 2022

A randomized clinical trial sought to determine if high-dose dexamethasone would be an effective palliative treatment of dyspnea in patients with cancer.

Bleeding Disorders

Assay Developed for the Measurement of Anti-Factor VIII Antibodies in Patients With Hemophilia A

Vicki Moore, PhD

November 9, 2022

Researchers sought to develop an assay for measuring neutralizing inhibitors and non-neutralizing antibodies in patients with hemophilia A.

General Hematology

Demographic Disparities Linked to Collected Cancer Family History Information

Vicki Moore, PhD

November 7, 2022

A retrospective review of electronic health records in 2 large healthcare systems identified patients whose incomplete health information may contribute to disparities in cancer care.